These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18226204)

  • 41. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study.
    Hakama M; Pukkala E; Heikkilä M; Kallio M
    BMJ; 1997 Mar; 314(7084):864-7. PubMed ID: 9093096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme.
    Schouten LJ; de Rijke JM; Huveneers JA; Verbeek AL
    J Med Screen; 2002; 9(3):120-4. PubMed ID: 12370323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.
    Hellquist BN; Duffy SW; Nyström L; Jonsson H
    J Med Screen; 2012 Mar; 19(1):14-9. PubMed ID: 22355181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
    de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
    Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.
    Mannu GS; Wang Z; Broggio J; Charman J; Cheung S; Kearins O; Dodwell D; Darby SC
    BMJ; 2020 May; 369():m1570. PubMed ID: 32461218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Excess mortality from breast cancer in relation to mammography screening in northern Sweden.
    Lenner P; Jonsson H
    J Med Screen; 1997; 4(1):6-9. PubMed ID: 9200054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.
    Quinn M; Allen E
    BMJ; 1995 Nov; 311(7017):1391-5. PubMed ID: 8520272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Service screening mammography reduces breast cancer mortality among elderly women in Turku.
    Parvinen I; Helenius H; Pylkkänen L; Anttila A; Immonen-Räihä P; Kauhava L; Räsänen O; Klemi PJ
    J Med Screen; 2006; 13(1):34-40. PubMed ID: 16569304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region.
    Wu JC; Anttila A; Yen AM; Hakama M; Saarenmaa I; Sarkeala T; Malila N; Auvinen A; Chiu SY; Chen TH
    Breast Cancer Res Treat; 2010 Jun; 121(3):671-8. PubMed ID: 19890708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes.
    Törnberg S; Carstensen J; Hakulinen T; Lenner P; Hatschek T; Lundgren B
    J Med Screen; 1994 Jul; 1(3):184-7. PubMed ID: 8790514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effectiveness of population-based breast cancer screening programme].
    Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
    Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast cancer mortality in organised mammography screening in Denmark: comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMJ; 2010 Mar; 340():c1241. PubMed ID: 20332505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 54. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mortality reductions due to mammography screening: Contemporary population-based data.
    Hanley JA; Hannigan A; O'Brien KM
    PLoS One; 2017; 12(12):e0188947. PubMed ID: 29261685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of screening mammography on the surgery of breast cancer in Finland: a population-based analysis during the years 1985-2004.
    Paajanen H; Kyhälä L; Varjo R; Rantala S
    Am Surg; 2006 Feb; 72(2):167-71. PubMed ID: 16536250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes.
    Taylor R; Supramaniam R; Rickard M; Estoesta J; Moreira C
    J Med Screen; 2002; 9(1):20-5. PubMed ID: 11943793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validity of process indicators of screening for breast cancer to predict mortality reduction.
    Sarkeala T; Anttila A; Saarenmaa I; Hakama M
    J Med Screen; 2005; 12(1):33-7. PubMed ID: 15814017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme.
    Séradour B; Estève J; Heid P; Jacquemier J
    J Med Screen; 1999; 6(2):99-102. PubMed ID: 10444729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.